Ellevest’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
Ellevest's NVO Position: Q3 2026 in Review
Ellevest reduced its Novo Nordisk (NVO) stake by 5.8% in Q3 2026, selling an estimated $41.4K and leaving 14,476 shares worth $574K. The position accounts for 0.07% of the portfolio, ranked #214.
Ellevest first reported a position in NVO in Q2 2019 and has held it in 29 quarters since. The position peaked at $3.3M in Q2 2024. 1,061 funds tracked by Wall St. Rank hold NVO as of Q3 2026.
- Ellevest held 14,476 shares of Novo Nordisk worth $574K as of Q3 2026.
- Ellevest sold 897 Novo Nordisk shares in Q3 2026, an estimated $41.4K.
- Novo Nordisk made up 0.07% of Ellevest's portfolio in Q3 2026, its #214 holding.
- Ellevest first reported a position in Novo Nordisk in Q2 2019 and has held it in 29 quarters since.
- Ellevest's Novo Nordisk position peaked at $3.3M in Q2 2024.
- 1,061 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.
Based on Ellevest's 13F filing for Q3 2026, filed 10 Nov 2026.